Alzheimer’s disease (AD) is a neurodegenerative condition affecting millions of people worldwide. It is associated with cerebral amyloid-β (Aβ) plaque deposition in the brain, synaptic disconnection, and subsequent progressive neuronal death. Although considerable progress has been made to elucidate the pathogenesis of AD, the specific causes of the disease remain highly unknown. Recent research has suggested a potential association between certain infectious diseases and dementia, either directly due to bacterial brain invasion and toxin production, or indirectly by modulating the immune response. Therefore, in the present review we focus on the emerging issues of bacterial infection and AD, including the existence of antimicrobial peptides having pore-forming properties that act in a similar way to pores formed by Aβ in a variety of cell membranes. Special focus is placed on oral bacteria and biofilms, and on the potential mechanisms associating bacterial infection and toxin production in AD. The role of bacterial outer membrane vesicles on the transport and delivery of toxins as well as porins to the brain is also discussed. Aβ has shown to possess antimicrobial activity against several bacteria, and therefore could be upregulated as a response to bacteria and bacterial toxins in the brain. Although further research is needed, we believe that the control of biofilm-mediated diseases could be an important potential prevention mechanism for AD development.
CorderE, SaundersA, StrittmatterW, SchmechelD, GaskellP, SmallG, RosesA, HainesJ, Pericak-VanceM (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science261, 921–923.
7.
BrindleN, St.George-Hyslop P (2000) The genetics of Alzheimer’s disease. In Alzheimer’s Disease: Methods and Protocols, HooperNM, ed. Humana Press, Totowa, NJ, pp. 23–43.
8.
MayeuxR, SternY, OttmanR, TatemichiTK, TangMX, MaestreG, NgaiC, TyckoB, GinsbergH (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Ann Neurol34, 752–754.
9.
StandridgeJB (2004) Pharmacotherapeutic approaches to the prevention of Alzheimer’s disease. Am J Geriatr Pharmacother2, 119–132.
10.
IttnerLM, GötzJ (2011) Amyloid-β and tau - A toxic pas de deux in Alzheimer’s disease. Nat Rev Neurosci12, 67–72.
11.
ShojiM, GoldeTE, GhisoJ, CheungTT, EstusS, ShafferLM, CaiXD, McKayDM, TintnerR, FrangioneB (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science258, 126–129.
12.
TurnerPR, O’ConnorK, TateWP, AbrahamWC (2003) Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog Neurobiol70, 1–32.
13.
HardyJ (2006) A hundred years of Alzheimer’s disease research. Neuron52, 3–13.
14.
ShankarGM, BloodgoodBL, TownsendM, WalshDM, SelkoeDJ, SabatiniBL (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci27, 2866–2875.
15.
SepúlvedaFJ, FierroH, FernandezE, CastilloC, PeoplesRW, OpazoC, AguayoLG (2014) Nature of the neurotoxic membrane actions of amyloid-β on hippocampal neurons in Alzheimer’s disease. Neurobiol Aging35, 472–481.
16.
LesnéS, KohMT, KotilinekL, KayedR, GlabeCG, YangA, GallagherM, AsheKH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature440, 352–7.
PetersC, Fernandez-PerezEJ, BurgosCF, EspinozaMP, CastilloC, UrrutiaJC, StreltsovVA, OpazoC, AguayoLG (2013) Inhibition of amyloid beta-induced synaptotoxicity by a pentapeptide derived from the glycine zipper region of the neurotoxic peptide. Neurobiol Aging34, 2805–2814.
19.
MajdS, PowerJH, GranthamHJM (2015) Neuronal response in Alzheimer’s and Parkinson’s disease: The effect of toxic proteins on intracellular pathways. BMC Neurosci16, 69.
20.
MacleodR, HillertE-K, CameronRT, BaillieGS (2015) The role and therapeutic targeting of α-, β- and γ-secretase in Alzheimer’s disease. Futur Sci OA1, 1–16.
21.
YoshiyamaY, LeeVMY, TrojanowskiJQ (2013) Therapeutic strategies for tau mediated neurodegeneration. J Neurol Neurosurg Psychiatry84, 784–795.
22.
SimićG, BabićLeko M, WrayS, HarringtonC, DelalleI, Jovanov-MilosevićN, BažadonaD, BuéeL, de SilvaR, GiovanniG Di, WischikC, HofPR (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer’s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules6, 2–28.
23.
BinderLi, FrankfurterA, RebhunLi (1986) Differential localization of MAP-2 and tau in mammalian neurons in situ. Ann N Y Acad Sci466, 145–166.
24.
MartinL, LatypovaX, WilsonCM, MagnaudeixA, PerrinML, YardinC, TerroF (2013) Tau protein kinases: Involvement in Alzheimer’s disease. Ageing Res Rev12, 289–309.
25.
IqbalK, LiuF, GongC-X, Grundke-IqbalI (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res7, 656–664.
Fernandez-PerezEJ, PetersC, AguayoLG (2016) Membrane damage induced by amyloid beta and a potential link with neuroinflammation. Curr Pharm Des22, 1295–304.
28.
SepulvedaFJ, ParodiJ, PeoplesRW, OpazoC, AguayoLG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One5, 7, e11820.
29.
DiazJC, SimakovaO, JacobsonK a, ArispeN, PollardHB (2009) Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity. Proc Natl Acad Sci U S A106, 3348–3353.
30.
DeMarshallCA, NageleEP, SarkarA, AcharyaNK, GodseyG, GoldwaserEL, KosciukM, ThayasivamU, HanM, BelinkaB, NageleRG (2016) Detection of Alzheimer’s disease at mild cognitive impairment and disease progression using autoantibodies as blood-based biomarkers. Alzheimers Dement (N Y)3, 1–12.
31.
RissmanRA, TrojanowskiJQ, ShawLM, AisenPS (2012) Longitudinal plasma amyloid beta as a biomarker of Alzheimer’s disease. J Neural Transm119, 843–850.
32.
Graff-RadfordNR, CrookJE, LucasJ, BoeveBF, KnopmanDS, IvnikRJ, SmithGE, YounkinLH, PetersenRC, YounkinSG (2007) Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Arch Neurol64, 354–362.
33.
SosciaSJ, KirbyJE, WashicoskyKJ, TuckerSM, IngelssonM, HymanB, BurtonMA, GoldsteinLE, DuongS, TanziRE, MoirRD (2010) The Alzheimer’s disease-associated amyloid β-protein is an antimicrobial peptide, PLoS One5, 3, e9505.
34.
KumarDK, ChoiSH, WashicoskyKJ, EimerWA, TuckerS, GhofraniJ, LefkowitzA, McCollG, GoldsteinLE, TanziRE, MoirRD (2016) Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci Transl Med8, 340ra72.
35.
BourgadeK, GarneauH, GirouxG, Le PageAY, BoctiC, DupuisG, FrostEH, FülöpT (2014) β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology16, 85–98.
36.
HarrisSA, HarrisEA (2015) Herpes simplex virus type 1 and other pathogens are key causative factors in sporadic Alzheimer’s disease. J Alzheimers Dis48, 319–353.
37.
JohnsonRT, GibbsCJJr (1998) Creutzfeldt-Jakob disease and related transmissible spongiform encephalopathies. N Engl J Med339, 1994–2004.
38.
KojimaG, TatsunoBK, InabaM, VelligasS, MasakiK, LiowKK (2013) Creutzfeldt-Jakob disease: A case report and differential diagnoses. Hawaii J Med Public Heal72, 136–139.
39.
SikorskaB, LiberskiPP (2012) Human prion diseases: From Kuru to variant Creutzfeldt-Jakob disease. Subcell Biochem65, 457–96.
40.
SikorskaB, KnightR, IronsideJW, LiberskiPP (2012) Creutzfeldl-Jakob disease. In Neurodegenerative Diseases, AhmadSI, ed. Springer US, New York, NY, pp. 76–90.
41.
AlmeidaOP, LautenschlagerNT (2005) Dementia associated with infectious diseases. Int Psychogeriatrics17, S65.
42.
MiklossyJ (2015) Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front Aging Neurosci7, 46.
43.
MiklossyJ (2011) Alzheimer’s disease - a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J Neuroinflammation8, 90.
44.
SadasivanS, SharpB, Schultz-CherryS, SmeyneRJ (2017) Synergistic effects of influenza and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) can be eliminated by the use of influenza therapeutics: Experimental evidence for the multi-hit hypothesis. NPJ Parkinsons Dis3, 18.
45.
ParsekMR, SinghPK (2003) Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol57, 677–701.
46.
Van AckerH, Van DijckP, CoenyeT (2014) Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol22, 326–333.
RosenbergM, BayerEA, DelareaJ, RosenbergE (1982) Role of thin fimbriae in adherence and growth of Acinetobacter calcoaceticus RAG-1 on hexadecane. Appl Environ Microbiol44, 929–937.
49.
AguayoS, StrangeA, GadegaardN, DalbyMJ, BozecL (2016) Influence of biomaterial nanotopography on the adhesive and elastic properties of Staphylococcus aureus cells. RSC Adv6, 89347–89355.
BanthiaR, ChandkiR, BanthiaP (2011) Biofilms: A microbial home. J Indian Soc Periodontol15, 111.
52.
Ximénez-FyvieLA, HaffajeeAD, SocranskySS (2000) Comparison of the microbiota of supra- and subgingival plaque in health and periodontitis. J Clin Periodontol27, 648–657.
53.
LavertyG, GormanS, GilmoreB (2014) Biomolecular mechanisms of Pseudomonas aeruginosa and Escherichia coli biofilm formation. Pathogens3, 596–632.
54.
GottschickC, DengZ-L, VitalM, MasurC, AbelsC, PieperDH, RohdeM, MendlingW, Wagner-DöblerI (2017) Treatment of biofilms in bacterial vaginosis by an amphoteric tenside pessary-clinical study and microbiota analysis. Microbiome5, 119.
HuttenhowerC, Human Microbiome Project Consortium (2012) Structure, function and diversity of the healthy human microbiome. Nature486, 207–214.
57.
CardingS, VerbekeK, VipondDT, CorfeBM, OwenLJ (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol Heal Dis26, 26191.
58.
AasJ a, PasterBJ, StokesLN, OlsenI, DewhirstFE (2005) Defining the normal bacterial flora of the oral cavity defining the normal bacterial flora of the oral cty. J Clin Microbiol43, 5721–5732.
59.
PasterBJ, BochesSK, GalvinJL, EricsonRE, LauCN, LevanosVA, SahasrabudheA, DewhirstFE (2001) Bacterial diversity in human subgingival plaque. J Bacteriol18312, 3770–3783.
60.
DewhirstFE, ChenT, IzardJ, PasterBJ, TannerACR, YuWH, LakshmananA, WadeWG (2010) The human oral microbiome. J Bacteriol192, 5002–5017.
O’DonnellLE, SmithK, WilliamsC, NileCJ, LappinDF, BradshawD, LambertM, RobertsonDP, BaggJ, HannahV, RamageG (2016) Dentures are a reservoir for respiratory pathogens. J Prosthodont25, 99–104.
65.
IinumaT, AraiY, AbeY, TakayamaM, FukumotoM, FukuiY, IwaseT, TakebayashiT, HiroseN, GionhakuN, KomiyamaK (2015) Denture wearing during sleep doubles the risk of pneumonia in the very elderly. J Dent Res94, 28S-36S.
66.
NomuraR, NakanoK, NemotoH, FujitaK, InagakiS, TakahashiT, TaniguchiK, TakedaM, YoshiokaH, AmanoA, OoshimaT (2006) Isolation and characterization of Streptococcus mutans in heart valve and dental plaque specimens from a patient with infective endocarditis. J Med Microbiol55, 1135–1140.
67.
NomuraR, OtsuguM, NakaS, TeramotoN, KojimaA, MuranakaY, Matsumoto-NakanoM, OoshimaT, NakanoK (2014) Contribution of the interaction of Streptococcus mutans serotype k strains with fibrinogen to the pathogenicity of infective endocarditis. Infect Immun82, 5223–5234.
68.
NakanoK, InabaH, NomuraR, NemotoH, TakedaM, YoshiokaH, MatsueH, TakahashiT, TaniguchiK, AmanoA, OoshimaT (2006) Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol44, 3313–3317.
TyrovolasS, KoyanagiA, PanagiotakosDB, HaroJM, KassebaumNJ, ChrepaV, KotsakisGA (2016) Population prevalence of edentulism and its association with depression and self-rated health. Sci Rep6, 37083.
74.
LindenGJ, HerzbergMC (2013) Periodontitis and systemic diseases: A record of discussions of working group 4 of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases, J Clin Periodontol40(Suppl 14), S20–S23.
75.
LundHåheim L (2014) The infection hypothesis revisited: Oral infection and cardiovascular disease. Epidemiol Res Int2014, 1–9.
76.
HujoelPP, WhiteBA, GarcíaRI, ListgartenMA (2001) The dentogingival epithelial surface area revisited. J Periodontal Res36, 48–55.
77.
LoosBG, CraandijkJ, HoekFJ, DillenPMEW, VeldenU Van Der (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol71, 1528–1534.
78.
KampitsC, MontenegroMM, RibeiroIWJ, FurtadoM V, PolanczykCA, RösingCK, HaasAN (2016) Periodontal disease and inflammatory blood cytokines in patients with stable coronary artery disease. J Appl Oral Sci24, 352–358.
79.
ZhuH, LinX, ZhengP, ChenH (2015) Inflammatory cytokine levels in patients with periodontitis and/or coronary heart disease. Int J Clin Exp Pathol8, 2214–2220.
80.
HigashiY, GotoC, JitsuikiD, UmemuraT, NishiokaK, HidakaT, TakemotoH, NakamuraS, SogaJ, ChayamaK, YoshizumiM, TaguchiA (2008) Periodontal infection is associated with endothelial dysfunction in healthy subjects and hypertensive patients. Hypertension51, 446–453.
81.
de PabloP, ChappleILC, BuckleyCD, DietrichT (2009) Periodontitis in systemic rheumatic diseases. Nat Rev Rheumatol5, 218–224.
BorgnakkeWS (2015) Does treatment of periodontal disease influence systemic disease?Dent Clin North Am59, 885–917.
84.
KimAJ, LoAJ, PullinDA, Thornton-JohnsonDS, KarimbuxNY (2012) Scaling and root planing treatment for periodontitis to reduce preterm birth and low birth weight: A systematic review and meta-analysis of randomized controlled trials. J Periodontol83, 1508–1519.
85.
GentonL, CaniPD, SchrenzelJ (2015) Alterations of gut barrier and gut microbiota in food restriction, food deprivation and protein-energy wasting. Clin Nutr34, 341–349.
86.
TurnbaughPJ, HamadyM, YatsunenkoT, CantarelBL, DuncanA, LeyRE, SoginML, JonesWJ, RoeBA, AffourtitJP, EgholmM, HenrissatB, HeathAC, KnightR, GordonJI (2009) A core gut microbiome in obese and lean twins. Nature457, 480–484.
87.
BaileyMT, CoeCL (1999) Maternal separation disrupts the integrity of the intestinal microflora in infant rhesus monkeys. Dev Psychobiol35, 146–155.
88.
MoloneyRD, JohnsonAC, O’MahonySM, DinanTG, Greenwood-Van MeerveldB, CryanJF (2015) Greenwood-Van Meerveld B. Cryan JF (2015) Stress and the microbiota-gut-brain axis in visceral pain: Relevance to irritable bowel syndrome. CNS Neurosci Ther22, 102–117.
89.
BekkeringP, JafriI, van OverveldFJ, RijkersGT (2013) The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes. Expert Rev Clin Immunol9, 1031–1041.
90.
Dominguez-BelloMG, CostelloEK, ContrerasM, MagrisM, HidalgoG, FiererN, KnightR (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A107, 11971–11975.
91.
BergströmA, SkovTH, BahlMI, RoagerHM, ChristensenLB, EjlerskovKT, MølgaardC, MichaelsenKF, LichtTR (2014) Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol80, 2889–2900.
92.
HarmsenHJ, Wildeboer-VelooAC, RaangsGC, WagendorpAA, KlijnN, BindelsJG, WellingGW (2000) Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr30, 61–67.
93.
KimD, ZengMY, NúñezG (2017) The interplay between host immune cells and gut microbiota in chronic inflammatory diseases. Exp Mol Med49, e339.
94.
LeyR, TurnbaughP, KleinS, GordonJ (2006) Microbial ecology: Human gut microbes associated with obesity. Nature444, 1022–3.
95.
LeyRE, BackhedF, TurnbaughP, LozuponeCA, KnightRD, GordonJI (2005) Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A102, 11070–11075.
96.
AjslevTA, AndersenCS, GamborgM, SørensenTIA, JessT (2011) Childhood overweight after establishment of the gut microbiota: The role of delivery mode, pre-pregnancy weight and early administration of antibiotics. Int J Obes35, 522–529.
WroblewskiLE, PeekRM, WilsonKT (2010) Helicobacter pylori and gastric cancer: Factors that modulate disease risk. Clin Microbiol Rev23, 713–739.
99.
WangF, MengW, WangB, QiaoL (2014) Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett345, 196–202.
100.
HofmanVJ, MoreilhonC, BrestPD, LassalleS, LeBrigand K, SicardD, RaymondJ, LamarqueD, HébuterneXA, MariB, BarbryPJ, HofmanPM (2007) Gene expression profiling in human gastric mucosa infected with Helicobacter pylori. Mod Pathol20, 974–989.
101.
ShimizuT, MarusawaH, WatanabeN, ChibaT (2015) Molecular pathogenesis of Helicobacter pylori-related gastric cancer. Gastroenterol Clin North Am44, 625–638.
102.
NoachLA, BosmaNB, JansenJ, HoekFJ, van DeventerSJ, TytgatGN (1994) Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol29, 425–429.
103.
EmeryDC, ShoemarkDK, BatstoneTE, WaterfallCM, CoghillJA, CerajewskaTL, DaviesM, WestNX, AllenSJ (2017) 16S rRNA next generation sequencing analysis shows bacteria in Alzheimer’s post-mortem brain. Front Aging Neurosci9, 195.
104.
PisaD, AlonsoR, Fernández-FernándezAM, RábanoA, CarrascoL (2017) Polymicrobial infections in brain tissue from Alzheimer’s disease patients. Sci Rep7, 5559.
105.
LittleCS, HammondCJ, MacIntyreA, BalinBJ, AppeltDM (2004) Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging25, 419–429.
106.
WozniakMA, FrostAL, ItzhakiRF (2009) Alzheimer’s disease-specific tau phosphorylation is induced by herpes simplex virus type 1. J Alzheimers Dis16, 341–50.
107.
RameshG, BordaJT, DufourJ, KaushalD, RamamoorthyR, LacknerAA, PhilippMT (2008) Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol173, 1415–1427.
108.
CharonNW, GoldsteinSF (2002) Genetics of motility and chemotaxis of a fascinating group of bacteria: The spirochetes. Annu Rev Genet36, 47–73.
109.
WolgemuthCW (2015) Flagellar motility of the pathogenic spirochetes. Semin Cell Dev Biol46, 104–112.
110.
MaheshwariP, EslickGD (2015) Bacterial infection and Alzheimer’s disease: A meta-analysis. J Alzheimers Dis43, 957–966.
111.
AllenHB, MoralesD, JonesK, JoshiS (2016) Alzheimer’s disease: A novel hypothesis integrating spirochetes, biofilm, and the immune system. Neuroinfectious Dis7, 1–3.
112.
KamerAR, DasanayakeA, CraigRG, Glodzik-SobanskaL, BryM, De LeonMJ (2008) Alzheimer’s disease and peripheral infections: The possible contribution from periodontal infections, model and hypothesis. J Alzheimers Dis13, 437–449.
MacDonaldAB (1988) Concurrent neocortical borreliosis and Alzheimer’s disease: Demonstration of a spirochetal cyst form. Ann N Y Acad Sci539, 468–470.
115.
MiklossyJ, KhaliliK, GernL, EricsonRL, DarekarP, BolleL, HurlimannJ, PasterBJ (2004) Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J Alzheimers Dis6, 639–649.
116.
MiklossyJ, KisA, RadenovicA, MillerL, ForroL, MartinsR, ReissK, DarbinianN, DarekarP, MihalyL, KhaliliK (2006) Beta-amyloid deposition and Alzheimer’s type changes induced by Borrelia spirochetes. Neurobiol Aging27, 228–236.
117.
GutackerM, ValsangiacomoC, BalmelliT, BernasconiMVI, BourasC, PiffarettiJC (1998) Arguments against the involvement of Borrelia burgdorferi sensu lato in Alzheimer’s disease. Res Microbiol149, 31–37.
118.
GalbusseraA, TremolizzoL, IsellaV, GelosaG, VezzoR, VigorèL, BrennaM, FerrareseC, AppollonioI (2008) Lack of evidence for Borrelia burgdorferi seropositivity in Alzheimer disease. Alzheimer Dis Assoc Disord22, 308.
RiviereG, RiviereKH, SmithKS (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease. Oral Microbiol Immunol17, 113–118.
121.
MiklossyJ (2016) Bacterial amyloid and DNA are important constituents of senile plaques: Further evidence of the spirochetal and biofilm nature of senile plaques. J Alzheimers Dis53, 1459–1473.
122.
MiklossyJ (2008) Chronic inflammation and amyloidogenesis in Alzheimer’s disease – role of spirochetes. J Alzheimers Dis13, 381–391.
123.
LukehartSA, HookEW, Baker-ZanderSA, CollierAC, CritchlowCW, HandsfieldHH (1988) Invasion of the central nervous system by Treponema pallidum: Implications for diagnosis and treatment. Ann Intern Med109, 855–862.
124.
WangJ, GuoQ, ZhouP, ZhangJ, ZhaoQ, HongZ (2011) Cognitive impairment in mild general paresis of the insane: AD-like pattern. Dement Geriatr Cogn Disord31, 284–290.
125.
SinghraoSK, HardingA, PooleS, KesavaluL, CreanSJ (2015) Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators Inflamm2015, 137357.
126.
KamerAR, CraigRG, PirragliaE, DasanayakeAP, NormanRG, BoylanRJ, NehorayoffA, GlodzikL, BrysM, de LeonMJ (2009) TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects. J Neuroimmunol216, 92–97.
127.
PooleS, SinghraoSK, KesavaluL, CurtisMA, CreanSJ (2013) Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J Alzheimers Dis36, 665–677.
128.
Hauss-WegrzyniakB, WenkGL (2002) Beta-amyloid deposition in the brains of rats chronically infused with thiorphan or lipopolysaccharide: The role of ascorbic acid in the vehicle. Neurosci Lett322, 75–78.
129.
LeeJ, LeeY, YukD, ChoiD, BanS, OhK, HongJ (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation5, 37.
130.
CarterCJ, FranceJ, CreanSJ, SinghraoSK (2017) The Porphyromonas gingivalis/Host Interactome shows enrichment in GWASdb genes related to Alzheimer’s disease, diabetes and cardiovascular diseases. Front Aging Neurosci9, 408.
131.
NobleJM, BorrellLN, PapapanouPN, ElkindMS V, ScarmeasN, WrightCB (2009) Periodontitis is associated with cognitive impairment among older adults: Analysis of NHANES-III. J Neurol Neurosurg Psychiatry80, 1206–1211.
132.
PooleS, SinghraoSK, ChukkapalliS, RiveraM, VelskoI, KesavaluL, CreanS (2015) Active invasion of porphyromonas gingivalis and infection-induced complement activation in ApoE -/- mice brains. J Alzheimers Dis43, 67–80.
133.
TeixeiraFB, SaitoMT, MatheusFC, PredigerRD, YamadaES, MaiaCSF, LimaRR (2017) Periodontitis and Alzheimer’s disease: A possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci9, 327.
134.
NobleJM, ScarmeasN, CelentiRS, ElkindMS V, WrightCB, SchupfN, PapapanouPN (2014) Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease. PLoS One9, e114959.
135.
Sparks SteinP, SteffenMJ, SmithC, JichaG, EbersoleJL, AbnerE, DawsonD (2012) Serum antibodies to periodontal pathogens are a risk factor for Alzheimer’s disease. Alzheimers Dement8, 196–203.
136.
WangQ-Q, ZhangC-F, ChuC-H, ZhuX-F (2012) Prevalence of Enterococcus faecalis in saliva and filled root canals of teeth associated with apical periodontitis. Int J Oral Sci4, 19–23.
137.
MylonaE, VadalaC, PapastamopoulosV, SkoutelisA (2012) Brain abscess caused by Enterococcus faecalis following a dental procedure in a patient with hereditary hemorrhagic telangiectasia. J Clin Microbiol50, 1807–1809.
138.
UnderlyR, SongM-S, DunbarGL, WeaverCL (2015) Expression of Alzheimer-type neurofibrillary epitopes in primary rat cortical neurons following infection with Enterococcus faecalis. Front Aging Neurosci7, 259.
139.
BattyGD, LiQ, HuxleyR, ZoungasS, TaylorBA, NealB, de GalanB, WoodwardM, HarrapSB, ColagiuriS, PatelA, ChalmersJ (2013) Oral disease in relation to future risk of dementia and cognitive decline: Prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial. Eur Psychiatry28, 49–52.
140.
LiJ, XuH, PanW, WuB (2017) Association between tooth loss and cognitive decline: A 13-year longitudinal study of Chinese older adults. PLoS One12, e0171404.
141.
StewartR, WeyantRJ, GarciaME, HarrisT, LaunerLJ, SatterfieldS, SimonsickEM, YaffeK, NewmanAB (2013) Adverse oral health and cognitive decline: The health, aging and body composition study. J Am Geriatr Soc61, 177–184.
142.
Van Der VeldenU, AmaliyaA, LoosBG, TimmermanMF, Van Der WeijdenFA, WinkelEG, AbbasF (2015) Java project on periodontal diseases: Causes of tooth loss in a cohort of untreated individuals. J Clin Periodontol42, 824–831.
143.
HooiJKY, LaiWY, NgWK, SuenMMY, UnderwoodFE, TanyingohD, MalfertheinerP, GrahamDY, WongVWS, WuJCY, ChanFKL, SungJJY, KaplanGG, NgSC (2017) Global prevalence of Helicobacter pylori infection: Systematic review and meta-analysis. Gastroenterology153, 420–429.
144.
KountourasJ, BozikiM, GavalasE, ZavosC, GrigoriadisN, DeretziG, TzilvesD, KatsinelosP, TsolakiM, ChatzopoulosD, VenizelosI (2009) Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer’s disease. J Neurol256, 758–767.
145.
FeliceC, FedericoC, AndreaF, RiccardoAC, WalterS, DomenicoI, ChiaraM, RosannaC (2017) The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible. Sci Rep7, 7817.
146.
Romero-AdriánTB, Leal-MontielJ, Monsalve-CastilloF, Mengual-MorenoE, McGregorEG, PeriniL, AntúnezA (2010) Helicobacter pylori: Bacterial factors and the role of cytokines in the immune response. Curr Microbiol60, 143–155.
147.
Wyss-CorayT, RogersJ (2012) Inflammation in Alzheimer disease-A brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med2, a006346.
148.
MinterMR, ZhangC, LeoneV, RingusDL, ZhangX, Oyler-CastrilloP, MuschMW, LiaoF, WardJF, HoltzmanDM, ChangEB, TanziRE, SisodiaSS (2016) Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci Rep6, 30028.
149.
LiangS, WangT, HuX, LuoJ, LiW, WuX, DuanY, JinF (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience310, 561–577.
150.
WangT, HuX, LiangS, LiW, WuX, WangL, JinF (2015) Lactobacillus fermentum NS9 restores the antibiotic induced physiological and psychological abnormalities in rats. Benef Microbes6, 707–717.
151.
OhsawaK, UchidaN, OhkiK, NakamuraY, YokogoshiH (2015) Lactobacillus helveticus-fermented milk improves learning and memory in mice. Nutr Neurosci18, 232–40.
152.
LuoJ, WangT, LiangS, HuX, LiW, JinF (2014) Ingestion of Lactobacillus strain reduces anxiety and improves cognitive function in the hyperammonemia rat. Sci China Life Sci57, 327–335.
153.
SavignacHM, TramullasM, KielyB, DinanTG, CryanJF (2015) Bifidobacteria modulate cognitive processes in an anxious mouse strain. Behav Brain Res287, 59–72.
154.
AllenAP, HutchW, BorreYE, KennedyPJ, TemkoA, BoylanG, MurphyE, CryanJF, DinanTG, ClarkeG (2016) Bifidobacterium longum 1714 as a translational psychobiotic: Modulation of stress, electrophysiology and neurocognition in healthy volunteers. Transl Psychiatry6, e939.
155.
SchwartzK, BolesBR (2013) Microbial amyloids - functions and interactions within the host. Curr Opin Microbiol16, 93–99.
156.
HufnagelDA, TukelC, ChapmanMR (2013) Disease to dirt: The biology of microbial amyloids. PLoS Pathog9, e1003740.
BlancoLP, EvansML, SmithDR, BadtkeMP, ChapmanMR (2012) Diversity, biogenesis and function of microbial amyloids. Trends Microbiol20, 66–73.
159.
CryanJF, O’MahonySM (2011) The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil23, 187–192.
160.
CryanJF, DinanTG (2012) Mind-altering microorganisms: The impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci13, 701–712.
161.
CollinsSM, SuretteM, BercikP (2012) The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol10, 735–742.
162.
SherwinE, ReaK, DinanTG, CryanJF (2016) A gut (microbiome) feeling about the brain. Curr Opin Gastroenterol32, 96–102.
163.
MuQ, KirbyJ, ReillyCM, LuoXM (2017) Leaky gut as a danger signal for autoimmune diseases. Front Immunol8, 598.
164.
KhaleghiS, JuJM, LambaA, MurrayJA (2016) The potential utility of tight junction regulation in celiac disease: Focus on larazotide acetate. Therap Adv Gastroenterol9, 37–49.
165.
FasanoA, Shea-DonohueT (2005) Mechanisms of disease: The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol2, 416–22.
166.
DesaiMS, SeekatzAM, KoropatkinNM, KamadaN, HickeyCA, WolterM, PudloNA, KitamotoS, TerraponN, MullerA, YoungVB, HenrissatB, WilmesP, StappenbeckTS, NúñezG, MartensEC (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell167,., 1339–1353.e21.
167.
ForderREA, HowarthGS, TiveyDR, HughesRJ (2007) Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry. Poult Sci86, 2396–2403.
AlaTA, DossRC, SullivanCJ (2004) Reversible dementia: A case of cryptococcal meningitis masquerading as Alzheimer’s disease. J Alzheimers Dis6, 503–508.
173.
HoffmannM, MunizJ, CarrollE, De VillasanteJ (2009) Cryptococcal meningitis misdiagnosed as Alzheimer’s disease: Complete neurological and cognitive recovery with treatment. J Alzheimers Dis16, 517–520.
174.
RumbaughJA, LiG, RothsteinJ, NathA (2007) Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. J Neurovirol13, 168–172.
175.
WangZ, PekarskayaO, BencheikhM, ChaoW, GelbardHA, GhorpadeA, RothsteinJD, VolskyDJ (2003) Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology312, 60–73.
176.
JuSM, SongHY, LeeJA, LeeSJ, ChoiSY, ParkJ (2009) Extracellular HIV-1 Tat up-regulates expression of matrix metalloproteinase-9 via a MAPK-NF-κB dependent pathway in human astrocytes. Exp Mol Med41, 86–93.
177.
KimK, LeeSG, KegelmanTP, SuZZ, DasSK, DashR, DasguptaS, BarralPM, HedvatM, DiazP, ReedJC, StebbinsJL, PellecchiaM, SarkarD, FisherPB (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J Cell Physiol226, 2484–2493.
178.
NakaeT (1976) Identification of the outer membrane protein of E. coli that produces transmembrane channels in reconstituted vesicle membranes. Biochem Biophys Res Commun71, 877–884.
179.
CowanSW, SchirmerT, RummelG, SteiertM, GhoshR, PauptitRA, JansoniusJN, RosenbuschJP (1992) Crystal structures explain functional properties of two E. coli porins. Nature358, 727–733.
180.
DutzlerR, RummelG, AlbertíS, Hernández-AllésS, PhalePS, RosenbuschJP, BenedíVJ, SchirmerT (1999) Crystal structure and functional characterization of OmpK36, the osmoporin of Klebsiella pneumoniae. Structure7, 425–434.
181.
HirschA, BreedJ, SaxenaK, RichterOMH, LudwigB, DiederichsK, WelteW (1997) The structure of porin from Paracoccus denitrificans at 3.1 Å resolution. FEBS Lett404, 208–210.
182.
ZethK, DiederichsK, WelteW, EngelhardtH (2000) Crystal structure of Omp32, the anion-selective porin from Comamonas acidovorans, in complex with a periplasmic peptide at 2.1Å resolution. Structure8, 981–992.
183.
MooreWEC, MooreLVH (1994) The bacteria of periodontal diseases. Periodontol 20005, 66–77.
184.
KleivdalH, BenzR, JensenHB (1995) The Fusobacterium nucleatum major outer-membrane protein (FomA) forms trimeric, water-filled channels in lipid bilayer membranes. Eur J Biochem233, 310–316.
185.
ZilmPS, MiraA, BagleyCJ, RogersAH (2010) Effect of alkaline growth pH on the expression of cell envelope proteins in Fusobacterium nucleatum. Microbiology156, 1783–1794.
186.
ChenA, SeifertHS (2013) Structure-function studies of the Neisseria gonorrhoeae major outer membrane porin. Infect Immun81, 4383–4391.
187.
PeakIR, JenningsCD, JenFEC, JenningsMP (2014) Role of neisseria meningitidis pora and porB expression in antimicrobial susceptibility. Antimicrob Agents Chemother58, 614–615.
188.
NovakMJ, CohenHJ (1991) Depolarization of polymorphonuclear leukocytes by Porphyromonas (Bacteroides) gingivalis 381 in the absence of respiratory burst activation. Infect Immun59, 3134–3142.
189.
HainesKA, YehL, BlakeMS, CristelloP, KorchakH, WeissmannG (1988) Protein I, a translocatable ion channel from Neisseria gonorrhoeae, selectively inhibits exocytosis from human neutrophils without inhibiting O2- generation. J Biol Chem263, 945–951.
190.
LynchEC, BlakeMS, GotschlichEC, MauroA (1984) Studies of porins: Spontaneously transferred from whole cells and reconstituted from purified proteins of Neisseria gonorrhoeae and Neisseria meningitidis. Biophys J45, 104–107.
191.
KelkarDA, ChattopadhyayA (2007) The gramicidin ion channel: A model membrane protein. Biochim Biophys Acta1768, 2011–2025.
192.
LiouJW, HungYJ, YangCH, ChenYC (2015) The antimicrobial activity of gramicidin a is associated with hydroxyl radical formation. PLoS One10, e0117065.
193.
DubosRJ, HotchkissRD (1941) The production of bactericidal substances by aerobic sporulating bacilli. J Exp Med73, 629–640.
194.
HelrichCS, SchmuckerJA, WoodburyDJ (2006) Evidence that nystatin channels form at the boundaries, not the interiors of lipid domains. Biophys J91, 1116–1127.
195.
AnandA, LeDoytM, KaranianC, LuthraA, Koszelak-RosenblumM, MalkowskiMG, PuthenveetilR, VinogradovaO, RadolfJD (2015) Bipartite topology of Treponema pallidum repeat proteins C/D and I: Outer membrane insertion, trimerization, and porin function require a C-Terminal B-barrel domain. J Biol Chem290, 12313–12331.
196.
EgliC, LeungWK, MullerKH, HancockREW, McBrideBC (1993) Pore-forming properties of the major 53-kilodalton surface antigen from the outer sheath of Treponema denticola. Infect Immun61, 1694–1699.
197.
MathersDA, LeungWK, FennoJC, HongY, McBrideBC (1996) The major surface protein complex of Treponema denticola depolarizes and induces ion channels in HeLa cell membranes. Infect Immun64, 2904–2910.
198.
TufanoMA, SommeseL, GaldieroF (1986) Some biological activities of Eikenella corrodens major outer membrane proteins. Eur J Epidemiol2, 305–311.
ZhouG, ZhouY, ChenX (2017) New insight into inter-kingdom communication: Horizontal transfer of mobile small RNAs. Front Microbiol8, 768.
201.
McBroomAJ, JohnsonAP, VemulapalliS, KuehnMJ (2006) Outer membrane vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol188, 5385–5392.
202.
SchaarV, NordströmT, MörgelinM, RiesbeckK (2011) Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob Agents Chemother55, 3845–3853.
VeithPD, ChenYY, GorasiaDG, ChenD, GlewMD, O’Brien-SimpsonNM, CecilJD, HoldenJA, ReynoldsEC (2014) Porphyromonas gingivalis outer membrane vesicles exclusively contain outer membrane and periplasmic proteins and carry a cargo enriched with virulence factors. J Proteome Res13, 2420–2432.
207.
PopadiakK, PotempaJ, RiesbeckK, BlomAM (2007) Biphasic effect of gingipains from porphyromonas gingivalis on the human complement system. J Immunol178, 7242–7250.
208.
NguyenKA, ZyliczJ, SzczesnyP, SrokaA, HunterN, PotempaJ (2009) Verification of a topology model of PorT as an integral outer-membrane protein in Porphyromonas gingivalis. Microbiology155, 328–337.
209.
ExnerMM, DoigP, TrustTJ, HancockREW (1995) Isolation and characterization of a family of porin proteins from Helicobacter pylori. Infect Immun63, 1567–1572.
210.
NestorovichEM, SugawaraE, NikaidoH, BezrukovSM (2006) Pseudomonas aeruginosa porin OprF. Properties of the channel. J Biol Chem281, 16230–16237.
211.
BoisvertH, DuncanMJ (2008) Clathrin-dependent entry of a gingipain adhesin peptide and Porphyromonas gingivalis into host cells. Cell Microbiol10, 2538–2552.
MontagneA, BarnesSR, SweeneyMD, HallidayMR, SagareAP, ZhaoZ, TogaAW, JacobsRE, LiuCY, AmezcuaL, HarringtonMG, ChuiHC, LawM, ZlokovicBV (2015) Blood-brain barrier breakdown in the aging human hippocampus, Neuron85, 296–302.
216.
DewhirstFE, TamerMA, EricsonRE, LauCN, LevanosVA, BochesSK, GalvinJL, PasterBJ (2000) The diversity of periodontal spirochetes by 16S rRNA analysis. Oral Microbiol Immunol15, 196–202.
217.
LeeY-C, ChiangT-H, ChouC-K, TuY-K, LiaoW-C, WuM-S, GrahamDY (2016) Association between Helicobacter pylori eradication and gastric cancer incidence: A systematic review and meta-analysis, Gastroenterology150, 51113–1124.e5.
